Skip to main content
NSPR logo
NSPR
(NASDAQ)
InspireMD, Inc.
$0.69-- (--)
Loading... - Market loading

InspireMD (NSPR) Company Profile

Complete business overview, executive team, trading details, and corporate information.

InspireMD, Inc.
NSPRNasdaq Stock MarketHealthcareMedical Devices

About InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Company Information

CEOMarvin Slosman
Founded2005
Employees127
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone888 776 6804
Address
6303 Waterford District Drive, Suite 215 Miami, Florida 33126 United States

Corporate Identifiers

CIK0001433607
CUSIP45779A853
ISINUS45779A8466
EIN26-2123838
SIC3841

Leadership Team & Key Executives

Marvin L. Slosman
President, Chief Executive Officer and Director
Michael A. Lawless
Chief Financial Officer, Secretary and Treasurer
Shane Thomas Gleason
Chief Commercial Officer
Donna DeChant
Vice President of Human Resources and Organizational Development
Amir Kohen
Executive Vice President of Finance and Regional Manager
Peter J. Ligotti
Executive Vice President and GM of North America
Dr. Peter A. Soukas M.D.
Chief Medical Officer
Dr. Sol J. Barer Ph.D.
Special Advisor to the Board